Clinical trial
PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung…
NCT00173524 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00173524 |
|---|---|
| Title | PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) |
| Official title | PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) : A Cost-Effectiveness Analysis and Cost-Utility Analysis |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Behavioral |
| Interventions | PharmacoEconomic Assessment |
| Enrollment | 200 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | May 19, 2009 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: